BlueBird Bio Drug Might Get Accelerated OK In U.S., Europe
May 19, 2015 at 14:31 PM EDT
Bluebird Bio Inc(NASDAQ: BLUE) fluttered up Tuesday on news that approvals for its LentiGlobin for treating a rare blood ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.